Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
06/2011
06/07/2011US7956049 Melanin concentrating hormone receptor-1 antagonists
06/07/2011CA2470515C Dna minor groove binding compounds
06/07/2011CA2423868C Carbamic acid compounds comprising an amide linkage as hdac inhibitors
06/03/2011WO2011066568A1 Methods for producing textured electrode based energy storage device
06/03/2011WO2011042473A3 Estrogen receptor ligands
06/03/2011WO2010149675A3 Method of synthesizing organic molecules
06/02/2011US20110130538 Photolytic acid-generating polymers and monomers for their construction
06/02/2011US20110130438 Aniline analogs as glycogen synthase activators
06/02/2011US20110129878 Bioreactive agents
06/01/2011EP2327789A1 Novel compound signamycin, method for production thereof, and use thereof
06/01/2011EP2327692A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
06/01/2011EP2327682A1 Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
06/01/2011EP2245006B1 Sulfonamides as orexin antagonists
06/01/2011CN102079703A Method for preparing novel nonsteroidal anti-inflammatory drug and anti-inflammatory and analgesic effects thereof
06/01/2011CN101432262B Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
06/01/2011CN101392227B Bacillus prodigiosus and prodigiosin produced thereby
06/01/2011CN101070300B Linonene anologs and its preparing method and use
06/01/2011CN101035757B Stabilizers for use in NVP synthesis
05/2011
05/31/2011US7951972 Human adam-10 inhibitors
05/31/2011US7951960 Black color material and toner
05/31/2011US7951939 Methods and intermediates for the synthesis of porphyrins
05/31/2011US7951752 O-cyclopropyl-carboxanilides and their use as fungicides
05/31/2011US7951211 Quaternary ammonium salt detergents for use in fuels
05/31/2011CA2634299C Process for preparing inhibitors of nucleoside metabolism
05/31/2011CA2603866C Androgen modulators
05/31/2011CA2475764C New inhibitors of histone deacetylase
05/31/2011CA2393232C Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in mri imaging of joints
05/31/2011CA2319080C Multivalent antibacterial agents
05/31/2011CA2172282C Chiral surfactants and methods for their use in chiral separations
05/26/2011WO2011023680A3 Processes for the synthesis and purification of heterobifunctional cross-linkers
05/26/2011WO2010144386A3 Antimicrobial polymers
05/26/2011US20110124882 Method for Preparing N-Substituted Maleimides
05/26/2011US20110124881 Process of forming a pyrrole compound
05/26/2011US20110124705 Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof
05/26/2011US20110124704 Deuterium-enriched atorvastatin
05/26/2011US20110123976 Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using NMR
05/26/2011US20110123873 Quaternary ammonium salt and composition, and electrochemical device
05/25/2011EP2325179A1 Glycosidase ihhibitors and preparation thereof
05/25/2011EP2325168A1 Polymerizable optically active imide compound and polymerizable composition containing the compound
05/25/2011EP2323977A1 Atorvastatin-aliskiren
05/25/2011EP2323976A1 Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
05/25/2011EP2323972A1 C7-fluoro substituted tetracycline compounds
05/25/2011EP1868994B1 Sulfonylpyrroles as histone deacetylase inhibitors
05/25/2011EP1680395B1 Novel ligand activating rar receptors used in human medicine and cosmetics
05/25/2011CN1926094B Amide derivatives, process for production of the same, and method for application thereof as insecticide
05/25/2011CN1863770B Cyclic amine BASE-1 inhibitors having a heterocyclic substituent
05/25/2011CN102076681A Substituted gamma lactams as therapeutic agents
05/25/2011CN102076655A Insecticidal compounds
05/25/2011CN102076650A Carboxylic acid compound
05/25/2011CN102070505A Atorvastatin calcium compounds and novel preparation method thereof
05/25/2011CN102070504A Method for preparing atorvastatin sodium
05/25/2011CN102070503A Method for preparing pyrrole derivative
05/25/2011CN102070502A Method for preparing (S)-4-hydroxide radical-2-oxo-1-pyrrolidine acetamide
05/25/2011CN102070501A Method for preparing n-methylpyrrolidone from 1,4-butanediol
05/25/2011CN102070451A Methods and compounds producing dipeptidyl peptidase IV inhibitors and intermediates thereof
05/25/2011CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof
05/24/2011US7947845 Process for purifying removal of acrylic acid, methacrylic acid N-vinylpyrrolidone or P-xylene crystals from their suspension in mother liquor
05/24/2011US7947730 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor
05/24/2011US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
05/24/2011US7947716 N-sulfonylaminocarbonyl containing compounds
05/24/2011US7947711 Bicyclic-substituted amines as histamine-3 receptor ligands
05/24/2011US7947707 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
05/24/2011US7947704 2,4,6-phenyl-substituted cyclic ketoenols
05/24/2011US7947513 Sets and compositions pertaining to analyte determination
05/24/2011US7947511 Intensified neutral loss tags and use thereof in mass spectrometry
05/24/2011US7947093 Quaternary ammonium salt detergents for use in fuels
05/24/2011CA2510167C Derivatives of asimadoline with covalently bonded acids
05/24/2011CA2464358C Alkyl ether derivatives or their salts
05/24/2011CA2441235C Aryl and biaryl compounds having mch modulatory activity
05/19/2011WO2011059042A1 Aromatic ring compound
05/19/2011WO2011058975A1 Agent for ameliorating postprandial hyperglycemia, and pyrrolidine iminosugar or salt thereof
05/19/2011WO2011058154A1 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators
05/19/2011WO2011058122A1 Piperidine analogs as glycogen synthase activators
05/19/2011WO2011057477A1 Tetrapeptide analogs, preparation method and use thereof
05/19/2011WO2011057430A1 Chiral n-sulfinyl amino acid amide compounds, preparation method and use thereof
05/19/2011WO2011009047A3 Il-1ra-polymer conjugates
05/19/2011WO2011004972A3 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist
05/19/2011WO2010149598A3 Heterocyclic antiviral compound
05/19/2011US20110118480 method of synthesizing a substantially monodispersed mixture of oligomers
05/19/2011US20110118470 Nitrogen-containing aromatic derivatives
05/19/2011US20110118329 Uses of ion channel modulating compounds
05/19/2011US20110118328 Novel crystalline forms
05/19/2011US20110118322 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators
05/19/2011US20110118314 Piperidine analogs as glycogen synthase activators
05/19/2011US20110118305 Compounds
05/19/2011US20110118303 Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these
05/19/2011US20110118262 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors
05/19/2011US20110117057 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
05/19/2011CA2789879A1 Dimeric smac mimetics
05/18/2011EP2322506A1 Histamine H3 receptor agents, preparation and therapeutic uses
05/18/2011EP2321274A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors
05/18/2011EP2321267A2 Monoaryl aminotetralines
05/18/2011EP2321011A1 Diaryl compounds and uses thereof
05/18/2011EP2320891A1 Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system
05/18/2011EP2046779B1 Modulators of chemokine receptor activity, crystalline forms and process
05/18/2011EP1834956B1 Metal complex compound and organic electroluminescent element using the same
05/18/2011EP1467969B1 Dna minor groove binding compounds
05/18/2011EP1192136B1 Oligomers and polymers of cyclic imino carboxylic acids
05/18/2011CN102066322A Compound having NPY Y5 receptor antagonist activity
05/18/2011CN102066321A Pyrrolidine derivatives as NK2 receptor antagonists
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 404